163 related articles for article (PubMed ID: 24960333)
1. Phase II drugs under clinical investigation for the treatment of chronic constipation.
Mozaffari S; Didari T; Nikfar S; Abdollahi M
Expert Opin Investig Drugs; 2014 Nov; 23(11):1485-97. PubMed ID: 24960333
[TBL] [Abstract][Full Text] [Related]
2. Early investigational therapeutics for gastrointestinal motility disorders: from animal studies to Phase II trials.
Valentin N; Acosta A; Camilleri M
Expert Opin Investig Drugs; 2015 Jun; 24(6):769-79. PubMed ID: 25971881
[TBL] [Abstract][Full Text] [Related]
3. Elobixibat for the treatment of constipation.
Wong BS; Camilleri M
Expert Opin Investig Drugs; 2013 Feb; 22(2):277-84. PubMed ID: 23215781
[TBL] [Abstract][Full Text] [Related]
4. Velusetrag for the treatment of chronic constipation.
Bassotti G; Gambaccini D; Bellini M
Expert Opin Investig Drugs; 2016 Aug; 25(8):985-90. PubMed ID: 27269187
[TBL] [Abstract][Full Text] [Related]
5. Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.
Mosińska P; Salaga M; Fichna J
Expert Opin Investig Drugs; 2016; 25(3):275-86. PubMed ID: 26765585
[TBL] [Abstract][Full Text] [Related]
6. Current and future therapies for chronic constipation.
Tack J
Best Pract Res Clin Gastroenterol; 2011 Feb; 25(1):151-8. PubMed ID: 21382586
[TBL] [Abstract][Full Text] [Related]
7. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
[TBL] [Abstract][Full Text] [Related]
8. New-generation 5-HT4 receptor agonists: potential for treatment of gastrointestinal motility disorders.
Manabe N; Wong BS; Camilleri M
Expert Opin Investig Drugs; 2010 Jun; 19(6):765-75. PubMed ID: 20408739
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of prucalopride in adults and children with chronic constipation.
Diederen K; Mugie SM; Benninga MA
Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
[TBL] [Abstract][Full Text] [Related]
10. Prucalopride: a new drug for the treatment of chronic constipation.
Tack J
Expert Rev Gastroenterol Hepatol; 2009 Aug; 3(4):337-43. PubMed ID: 19673621
[TBL] [Abstract][Full Text] [Related]
11. Current developments in pharmacological therapeutics for chronic constipation.
Jiang C; Xu Q; Wen X; Sun H
Acta Pharm Sin B; 2015 Jul; 5(4):300-9. PubMed ID: 26579459
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapeutic advances for chronic idiopathic constipation in adults.
Bassotti G; Usai Satta P; Berti G; Lai M; Villanacci V; Bellini M
Expert Opin Pharmacother; 2022 Dec; 23(18):2053-2078. PubMed ID: 36408585
[TBL] [Abstract][Full Text] [Related]
13. The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Gale JD
Adv Ther; 2009 May; 26(5):519-30. PubMed ID: 19444393
[TBL] [Abstract][Full Text] [Related]
14. Ghrelin as a target for gastrointestinal motility disorders.
Greenwood-Van Meerveld B; Kriegsman M; Nelson R
Peptides; 2011 Nov; 32(11):2352-6. PubMed ID: 21453735
[TBL] [Abstract][Full Text] [Related]
15. Pharmacologic treatment of constipation: what is new?
Pohl D; Tutuian R; Fried M
Curr Opin Pharmacol; 2008 Dec; 8(6):724-8. PubMed ID: 18687411
[TBL] [Abstract][Full Text] [Related]
16. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
Tack J; Corsetti M
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
[TBL] [Abstract][Full Text] [Related]
17. Elobixibat for the treatment of constipation.
Chedid V; Vijayvargiya P; Camilleri M
Expert Rev Gastroenterol Hepatol; 2018 Oct; 12(10):951-960. PubMed ID: 30204504
[TBL] [Abstract][Full Text] [Related]
18. Investigational drugs in Phase II clinical trials for the treatment of obesity: implications for future development of novel therapies.
Jackson VM; Price DA; Carpino PA
Expert Opin Investig Drugs; 2014 Aug; 23(8):1055-66. PubMed ID: 25000213
[TBL] [Abstract][Full Text] [Related]
19. Emerging drugs for chronic constipation.
Crowell MD; Harris LA; Lunsford TN; Dibaise JK
Expert Opin Emerg Drugs; 2009 Sep; 14(3):493-504. PubMed ID: 19650747
[TBL] [Abstract][Full Text] [Related]
20. The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide.
Lee N; Wald A
Expert Opin Drug Metab Toxicol; 2011 May; 7(5):651-9. PubMed ID: 21446888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
